Silent cerebrovascular lesion and cognitive decline prevention in atrial fibrillation by intensive cholesterol lowering in elderly patients.

Trial Profile

Silent cerebrovascular lesion and cognitive decline prevention in atrial fibrillation by intensive cholesterol lowering in elderly patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2012

At a glance

  • Drugs Ezetimibe (Primary) ; Simvastatin (Primary) ; Anticoagulants; Atorvastatin
  • Indications Atherosclerosis; Hypercholesterolaemia; Stroke; Thromboembolism
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms SPACE; SPACE-1
  • Most Recent Events

    • 01 Jan 2012 Results published in the International Journal of Geriatric Psychiatry.
    • 05 Sep 2007 Results have been presented
    • 29 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top